{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:19:38Z","timestamp":1791994778777,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81803546"],"award-info":[{"award-number":["No. 81803546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["No. ZR2018LH024 No. ZR2017MH068"],"award-info":[{"award-number":["No. ZR2018LH024 No. ZR2017MH068"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Shandong Laboratory Program","award":["SYS202205"],"award-info":[{"award-number":["SYS202205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02060-z","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:01:40Z","timestamp":1718362900000},"page":"346-360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Celastrol Regulates the Hsp90-NLRP3 Interaction to Alleviate Rheumatoid Arthritis"],"prefix":"10.1007","volume":"48","author":[{"given":"Junjie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longjiao","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"issue":"10086","key":"2060_CR1","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes, I.B., and G. Schett. 2017. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389 (10086): 2328\u20132337.","journal-title":"Lancet"},{"issue":"10055","key":"2060_CR2","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen, J.S., D. Aletaha, and I.B. McInnes. 2016. Rheumatoid arthritis. Lancet 388 (10055): 2023\u20132038.","journal-title":"Lancet"},{"key":"2060_CR3","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok, B., and G.S. Firestein. 2010. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunological Reviews 233: 233\u2013255.","journal-title":"Immunological Reviews"},{"issue":"5","key":"2060_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","volume":"54","author":"J Friscic","year":"2021","unstructured":"Friscic, J., M. Bottcher, C. Reinwald, H. Bruns, B. Wirth, S.J. Popp, K.I. Walker, J.A. Ackermann, X. Chen, J. Turner, et al. 2021. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity 54 (5): 1002.","journal-title":"Immunity"},{"key":"2060_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.intimp.2018.10.016","volume":"65","author":"RA Kumar","year":"2018","unstructured":"Kumar, R.A., Y. Li, Q.J. Dang, and F. Yang. 2018. Monocytes in rheumatoid arthritis: Circulating precursors of macrophages and osteoclasts and their heterogeneity and plasticity role in RA pathogenesis. International Immunopharmacology 65: 348\u2013359.","journal-title":"International Immunopharmacology"},{"issue":"1","key":"2060_CR6","doi-asserted-by":"publisher","first-page":"Itc1","DOI":"10.7326\/AITC201901010","volume":"170","author":"JA Sparks","year":"2019","unstructured":"Sparks, J.A. 2019. Rheumatoid Arthritis. Annals of Internal Medicine 170 (1): Itc1\u2013Itc15.","journal-title":"Annals of Internal Medicine"},{"key":"2060_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fmed.2017.00069","volume":"4","author":"R Cascao","year":"2017","unstructured":"Cascao, R., J.E. Fonseca, and L.F. Moita. 2017. Celastrol: A spectrum of treatment opportunities in chronic diseases. Frontiers in Medicine 4: 69.","journal-title":"Frontiers in Medicine"},{"issue":"2","key":"2060_CR8","doi-asserted-by":"publisher","first-page":"e134601","DOI":"10.1172\/jci.insight.134601","volume":"6","author":"G Xu","year":"2021","unstructured":"Xu, G., S. Fu, X. Zhan, Z. Wang, P. Zhang, W. Shi, N. Qin, Y. Chen, C. Wang, M. Niu, et al. 2021. Echinatin effectively protects against NLRP3 inflammasome-driven diseases by targeting HSP90. JCI Insight 6 (2): e134601.","journal-title":"JCI Insight"},{"key":"2060_CR9","doi-asserted-by":"publisher","first-page":"107879","DOI":"10.1016\/j.intimp.2021.107879","volume":"98","author":"M Jing","year":"2021","unstructured":"Jing, M., J.J. Yang, L.R. Zhang, J. Liu, S. Xu, M.L. Wang, L.M. Zhang, Y. Sun, W.B. Yan, G.G. Hou, et al. 2021. Celastrol inhibits rheumatoid arthritis through the ROS-NF-kappa B-NLRP3 inflammasome axis. International Immunopharmacology 98: 107879.","journal-title":"International Immunopharmacology"},{"issue":"23","key":"2060_CR10","doi-asserted-by":"publisher","first-page":"10798","DOI":"10.1021\/acs.jmedchem.9b01290","volume":"62","author":"N Li","year":"2019","unstructured":"Li, N., M.Y. Xu, B. Wang, Z.X. Shi, Z.H. Zhao, Y.Q. Tang, X.Y. Wang, J.B. Sun, and L. Chen. 2019. Discovery of novel celastrol derivatives as Hsp90-Cdc37 interaction disruptors with antitumor activity. Journal of Medicinal Chemistry 62 (23): 10798\u201310815.","journal-title":"Journal of Medicinal Chemistry"},{"issue":"51","key":"2060_CR11","doi-asserted-by":"publisher","first-page":"35381","DOI":"10.1074\/jbc.M109.051532","volume":"284","author":"T Zhang","year":"2009","unstructured":"Zhang, T., Y.Y. Li, Y.K. Yu, P. Zou, Y.Q. Jiang, and D.X. Sun. 2009. Characterization of celastrol to inhibit Hsp90 and Cdc37 interaction. Journal of Biological Chemistry 284 (51): 35381\u201335389.","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"2060_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imm.13267","volume":"162","author":"S Nizami","year":"2021","unstructured":"Nizami, S., K. Arunasalam, J. Green, J. Cook, C.B. Lawrence, T. Zarganes-Tzitzikas, J.B. Davis, E. Di Daniel, and D. Brough. 2021. Inhibition of the NLRP3 inflammasome by HSP90 inhibitors. Immunology 162 (1): 84\u201391.","journal-title":"Immunology"},{"issue":"2","key":"2060_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.tcb.2018.10.004","volume":"29","author":"TM Luengo","year":"2019","unstructured":"Luengo, T.M., M.P. Mayer, and S.G.D. Rudiger. 2019. The Hsp70-Hsp90 chaperone cascade in protein folding. Trends in Cell Biology 29 (2): 164\u2013177.","journal-title":"Trends in Cell Biology"},{"issue":"6","key":"2060_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nrm.2017.20","volume":"18","author":"FH Schopf","year":"2017","unstructured":"Schopf, F.H., M.M. Biebl, and J. Buchner. 2017. The HSP90 chaperone machinery. Nature Reviews Molecular Cell Biology 18 (6): 345\u2013360.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"6","key":"2060_CR15","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.bbamcr.2018.03.008","volume":"1865","author":"S Sima","year":"2018","unstructured":"Sima, S., and K. Richter. 2018. Regulation of the Hsp90 system. Biochimica Et Biophysica Acta-Molecular Cell Research 1865 (6): 889\u2013897.","journal-title":"Biochimica Et Biophysica Acta-Molecular Cell Research"},{"issue":"5","key":"2060_CR16","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3390\/ijms23052806","volume":"23","author":"M Fouani","year":"2022","unstructured":"Fouani, M., C.A. Basset, G.D. Mangano, L.G. Leone, N.B. Lawand, A. Leone, and R. Barone. 2022. Heat shock proteins alterations in rheumatoid arthritis. International Journal of Molecular Sciences 23 (5): 2806.","journal-title":"International Journal of Molecular Sciences"},{"issue":"12","key":"2060_CR17","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1002\/art.24047","volume":"58","author":"JW Rice","year":"2008","unstructured":"Rice, J.W., J.M. Veal, R.P. Fadden, A.F. Barabasz, J.M. Partridge, T.E. Barta, L.G. Dubois, K.H. Huang, S.R. Mabbett, M.A. Silinski, et al. 2008. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis and Rheumatism 58 (12): 3765\u20133775.","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"2060_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/ni1459","volume":"8","author":"A Mayor","year":"2007","unstructured":"Mayor, A., F. Martinon, T. De Smedt, V. Petrilli, and J. Tschopp. 2007. A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses. Nature Immunology 8 (5): 497\u2013503.","journal-title":"Nature Immunology"},{"issue":"6","key":"2060_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1083\/jcb.201312042","volume":"204","author":"A Ruggiano","year":"2014","unstructured":"Ruggiano, A., O. Foresti, and P. Carvalho. 2014. Quality control: ER-associated degradation: Protein quality control and beyond. Journal of Cell Biology 204 (6): 869\u2013879.","journal-title":"Journal of Cell Biology"},{"issue":"3","key":"2060_CR20","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00281-007-0079-y","volume":"29","author":"F Martinon","year":"2007","unstructured":"Martinon, F., O. Gaide, V. Petrilli, A. Mayor, and J. Tschopp. 2007. NALP Inflammasomes: A central role in innate immunity. Seminars in Immunopathology 29 (3): 213\u2013229.","journal-title":"Seminars in Immunopathology"},{"issue":"13","key":"2060_CR21","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3390\/ijms20133328","volume":"20","author":"N Kelley","year":"2019","unstructured":"Kelley, N., D. Jeltema, Y.H. Duan, and Y. He. 2019. The NLRP3 Inflammasome: An overview of mechanisms of activation and regulation. International Journal of Molecular Sciences 20 (13): 3328.","journal-title":"International Journal of Molecular Sciences"},{"key":"2060_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.biopha.2017.03.026","volume":"90","author":"N Haleagrahara","year":"2017","unstructured":"Haleagrahara, N., S. Miranda-Hernandez, M.A. Alim, L. Hayes, G. Bird, and N. Ketheesan. 2017. Therapeutic effect of quercetin in collagen-induced arthritis. Biomedicine and Pharmacotherapy 90: 38\u201346.","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"5","key":"2060_CR23","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand, D.D., K.A. Latham, and E.F. Rosloniec. 2007. Collagen-induced arthritis. Nature Protocols 2 (5): 1269\u20131275.","journal-title":"Nature Protocols"},{"key":"2060_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fphar.2019.00094","volume":"10","author":"Q Jia","year":"2019","unstructured":"Jia, Q., T.T. Wang, X.Y. Wang, H. Xu, Y. Liu, Y.J. Wang, Q. Shi, and Q.Q. Liang. 2019. Astragalin suppresses inflammatory responses and bone destruction in mice with collagen-induced arthritis and in human fibroblast-like synoviocytes. Frontiers in Pharmacology 10: 94.","journal-title":"Frontiers in Pharmacology"},{"key":"2060_CR25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fphar.2020.00515","volume":"11","author":"M Wang","year":"2020","unstructured":"Wang, M., H. Li, Y. Wang, Y. Hao, Y. Huang, X. Wang, Y. Lu, Y. Du, F. Fu, W. Xin, and L. Zhang. 2020. Anti-Rheumatic Properties of Gentiopicroside Are Associated With Suppression of ROS-NF-kappaB-NLRP3 Axis in Fibroblast-Like Synoviocytes and NF-kappaB Pathway in Adjuvant-Induced Arthritis. Frontiers in Pharmacology 11: 515.","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"2060_CR26","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.4049\/jimmunol.175.11.7687","volume":"175","author":"ML Toh","year":"2005","unstructured":"Toh, M.L., S.S. Hong, F.V. Loo, L. Franqueville, L. Lindholm, W.V.D. Berg, P. Boulanger, and P. Miossec. 2005. Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine-glycine-aspartic acid (RGD)- and non-RGD-binding integrins. The Journal of Immunology 175 (11): 7687\u20137698.","journal-title":"The Journal of Immunology"},{"key":"2060_CR27","doi-asserted-by":"publisher","first-page":"110542","DOI":"10.1016\/j.biopha.2020.110542","volume":"130","author":"Z Li","year":"2020","unstructured":"Li, Z., J.L. Guo, and L.Q. Bi. 2020. Role of the NLRP3 inflammasome in autoimmune diseases. Biomedicine and Pharmacotherapy 130: 110542.","journal-title":"Biomedicine and Pharmacotherapy"},{"issue":"7","key":"2060_CR28","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.autrev.2018.01.020","volume":"17","author":"HH Shen","year":"2018","unstructured":"Shen, H.H., Y.X. Yang, X. Meng, X.Y. Luo, X.M. Li, Z.W. Shuai, D.Q. Ye, and H.F. Pan. 2018. NLRP3: A promising therapeutic target for autoimmune diseases. Autoimmunity Reviews 17 (7): 694\u2013702.","journal-title":"Autoimmunity Reviews"},{"key":"2060_CR29","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3389\/fimmu.2020.01595","volume":"11","author":"XX Sun","year":"2020","unstructured":"Sun, X.X., H.P. Pang, J.Q. Li, S.M. Luo, G. Huang, X. Li, Z.G. Xie, and Z.G. Zhou. 2020. The NLRP3 inflammasome and its role in T1DM. Frontiers in Immunology 11: 1595.","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"2060_CR30","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1124\/pharmrev.120.000171","volume":"73","author":"SE Corcoran","year":"2021","unstructured":"Corcoran, S.E., R. Halai, and M.A. Cooper. 2021. Pharmacological inhibition of the nod-like receptor family pyrin domain containing 3 inflammasome with MCC950. Pharmacological Reviews 73 (3): 968\u20131000.","journal-title":"Pharmacological Reviews"},{"issue":"12","key":"2060_CR31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He, Y., H. Hara, and G. Nunez. 2016. Mechanism and regulation of NLRP3 inflammasome activation. Trends in Biochemical Sciences 41 (12): 1012\u20131021.","journal-title":"Trends in Biochemical Sciences"},{"issue":"9","key":"2060_CR32","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang, Y., W. Xu, and R.B. Zhou. 2021. NLRP3 inflammasome activation and cell death. Cellular & Molecular Immunology 18 (9): 2114\u20132127.","journal-title":"Cellular & Molecular Immunology"},{"issue":"5","key":"2060_CR33","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","volume":"22","author":"BR Sharma","year":"2021","unstructured":"Sharma, B.R., and T.D. Kanneganti. 2021. NLRP3 inflammasome in cancer and metabolic diseases. Nature Immunology 22 (5): 550\u2013559.","journal-title":"Nature Immunology"},{"issue":"9","key":"2060_CR34","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.3390\/ijms19092560","volume":"19","author":"A Hoter","year":"2018","unstructured":"Hoter, A., M.E. El-Sabban, and H.Y. Naim. 2018. The HSP90 family: structure, regulation, function, and implications in health and disease. International Journal of Molecular Sciences 19 (9): 2560.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"2060_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1158\/1535-7163.MCT-07-0484","volume":"7","author":"T Zhang","year":"2008","unstructured":"Zhang, T., A. Hamza, X.H. Cao, B. Wang, S.W. Yu, C.G. Zhan, and D.X. Sun. 2008. A novel Hsp90 inhibitor to disrupt Hsp90\/Cdc37 complex against pancreatic cancer cells. Molecular Cancer Therapeutics 7 (1): 162\u2013170.","journal-title":"Molecular Cancer Therapeutics"},{"issue":"1","key":"2060_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/imr.12908","volume":"297","author":"D Chauhan","year":"2020","unstructured":"Chauhan, D., L. Vande Walle, and M. Lamkanfi. 2020. Therapeutic modulation of inflammasome pathways. Immunological Reviews 297 (1): 123\u2013138.","journal-title":"Immunological Reviews"},{"issue":"6","key":"2060_CR37","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/acer.14338","volume":"44","author":"A Choudhury","year":"2020","unstructured":"Choudhury, A., D. Bullock, A. Lim, J. Argemi, P. Orning, E. Lien, R. Bataller, and P. Mandrekar. 2020. Inhibition of HSP90 and Activation of HSF1 Diminish Macrophage NLRP3 Inflammasome Activity in Alcohol-Associated Liver Injury. Alcohol-Clinical and Experimental Research 44 (6): 1300\u20131311.","journal-title":"Alcohol-Clinical and Experimental Research"},{"issue":"20","key":"2060_CR38","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.3390\/ijms20204976","volume":"20","author":"A Bohush","year":"2019","unstructured":"Bohush, A., P. Bieganowski, and A. Filipek. 2019. Hsp90 and its Co-chaperones in neurodegenerative diseases. International Journal of Molecular Sciences 20 (20): 4976.","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"2060_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tibs.2009.12.005","volume":"35","author":"Y Kadota","year":"2010","unstructured":"Kadota, Y., K. Shirasu, and R. Guerois. 2010. NLR sensors meet at the SGT1-HSP90 crossroad. Trends in Biochemical Sciences 35 (4): 199\u2013207.","journal-title":"Trends in Biochemical Sciences"},{"key":"2060_CR40","first-page":"82","volume":"1319","author":"FS Sutterwala","year":"2014","unstructured":"Sutterwala, F.S., S. Haasken, and S.L. Cassel. 2014. Mechanism of NLRP3 inflammasome activation. Year in Immunology: Myeloid Cells and Inflammation 1319: 82\u201395.","journal-title":"Year in Immunology: Myeloid Cells and Inflammation"},{"issue":"4","key":"2060_CR41","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","volume":"10","author":"H Hieronymus","year":"2006","unstructured":"Hieronymus, H., J. Lamb, K.N. Ross, X.P. Peng, C. Clement, A. Rodina, M. Nieto, J.Y. Du, K. Stegmaier, S.M. Raj, et al. 2006. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 10 (4): 321\u2013330.","journal-title":"Cancer Cell"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02060-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02060-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02060-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T06:07:37Z","timestamp":1739340457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02060-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["2060"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02060-z","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The animal experiment was approved by the Animal Protection and Use Committee of Binzhou Medical University (2018-20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}